New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 26, 2013
08:45 EDTNVGNNovogen to file family of provisional patents in the U.S.
Novogen announced the filing of a family of provisional patents in the US covering anti-tropomyosin drug technology. ATM drugs represent an entirely novel approach to anti-cancer therapy, blocking the ability of cancer cells to divide and doing so in a highly cancer-specific way. Based on their action, ATMs belong to a class of anti-cancer drug known as anti-mitotics. Current anti-mitotic drugs are taxanes and vinca alkaloids and remain among the most widely prescribed anti-cancer drugs after 40 years of use.
News For NVGN From The Last 14 Days
Check below for free stories on NVGN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for NVGN

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use